(SAM) Boston Beer - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1005571070
Beer, Cider, Seltzer
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 31.8% |
| Value at Risk 5%th | 47.2% |
| Relative Tail Risk | -9.85% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.31 |
| Alpha | -44.29 |
| CAGR/Max DD | -0.29 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.412 |
| Beta | 0.413 |
| Beta Downside | 0.277 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.14% |
| Mean DD | 29.83% |
| Median DD | 28.88% |
Description: SAM Boston Beer November 10, 2025
The Boston Beer Company (NYSE: SAM) is a U.S.-focused producer of alcoholic beverages, best known for its flagship Samuel Adams Boston Lager. Its portfolio spans traditional beers, hard ciders, flavored malt drinks, and hard seltzers under brands such as Twisted Tea, Truly, Angry Orchard, Dogfish Head, Angel City, and Coney Island, and it distributes through a wholesale network to retail channels ranging from grocery and convenience stores to bars, restaurants, and e-commerce platforms.
In FY 2024 the company reported net sales of $2.3 billion, a 7% year-over-year increase driven largely by double-digit growth in its hard-seltzer and ready-to-drink (RTD) segments, while its gross margin expanded to 45.2% thanks to premium pricing and improved supply-chain efficiencies.
Key macro drivers for SAM include the continued “premiumization” trend in the alcoholic-beverage market, where consumers are shifting spend toward higher-margin craft and RTD products, and the sensitivity of raw-material costs (barley, hops, sugar) to commodity price volatility and inflationary pressure.
For a deeper, data-rich assessment of SAM’s valuation dynamics, explore the analyst tools on ValueRay to see how these drivers stack up against peers.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income (92.2m TTM) > 0 and > 6% of Revenue (6% = 118.9m TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 4.58pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 10.56% (prev 13.57%; Δ -3.01pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.22 (>3.0%) and CFO 272.1m > Net Income 92.2m (YES >=105%, WARN >=100%) |
| Net Debt (-209.6m) to EBITDA (249.2m) ratio: -0.84 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.83 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (10.8m) change vs 12m ago -7.29% (target <= -2.0% for YES) |
| Gross Margin 47.72% (prev 43.95%; Δ 3.77pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 150.8% (prev 145.0%; Δ 5.74pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.66 (EBITDA TTM 249.2m / Interest Expense TTM 28.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.18
| (A) 0.17 = (Total Current Assets 461.8m - Total Current Liabilities 252.6m) / Total Assets 1.25b |
| (B) 0.18 = Retained Earnings (Balance) 220.8m / Total Assets 1.25b |
| (C) 0.12 = EBIT TTM 158.4m / Avg Total Assets 1.31b |
| (D) 0.66 = Book Value of Equity 220.4m / Total Liabilities 335.6m |
| Total Rating: 3.18 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.11
| 1. Piotroski 8.50pt |
| 2. FCF Yield 11.02% |
| 3. FCF Margin 10.69% |
| 4. Debt/Equity 0.04 |
| 5. Debt/Ebitda -0.84 |
| 6. ROIC - WACC (= 5.09)% |
| 7. RoE 10.15% |
| 8. Rev. Trend 22.06% |
| 9. EPS Trend 41.59% |
What is the price of SAM shares?
As of December 14, 2025, the stock is trading at USD 203.03 with a total of 124,839 shares traded.
Over the past week, the price has changed by +3.64%, over one month by +1.03%, over three months by -6.30% and over the past year by -36.37%.
Over the past week, the price has changed by +3.64%, over one month by +1.03%, over three months by -6.30% and over the past year by -36.37%.
Is SAM a buy, sell or hold?
Boston Beer has received a consensus analysts rating of 3.19.
Therefor, it is recommend to hold SAM.
- Strong Buy: 2
- Buy: 2
- Hold: 10
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the SAM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 243.2 | 19.8% |
| Analysts Target Price | 243.2 | 19.8% |
| ValueRay Target Price | 166.8 | -17.9% |
SAM Fundamental Data Overview December 09, 2025
Market Cap USD = 2.13b (2.13b USD * 1.0 USD.USD)
P/E Trailing = 22.7251
P/E Forward = 21.0084
P/S = 1.0764
P/B = 2.2919
P/EG = 0.7053
Beta = 1.059
Revenue TTM = 1.98b USD
EBIT TTM = 158.4m USD
EBITDA TTM = 249.2m USD
Long Term Debt = 936.0k USD (from longTermDebtTotal, last fiscal year)
Short Term Debt = 12.6m USD (from shortTermDebt, last quarter)
Debt = 40.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -209.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.92b USD (2.13b + Debt 40.9m - CCE 250.5m)
Interest Coverage Ratio = 5.66 (Ebit TTM 158.4m / Interest Expense TTM 28.0m)
FCF Yield = 11.02% (FCF TTM 211.9m / Enterprise Value 1.92b)
FCF Margin = 10.69% (FCF TTM 211.9m / Revenue TTM 1.98b)
Net Margin = 4.66% (Net Income TTM 92.2m / Revenue TTM 1.98b)
Gross Margin = 47.72% ((Revenue TTM 1.98b - Cost of Revenue TTM 1.04b) / Revenue TTM)
Gross Margin QoQ = 50.81% (prev 49.75%)
Tobins Q-Ratio = 1.54 (Enterprise Value 1.92b / Total Assets 1.25b)
Interest Expense / Debt = 4.02% (Interest Expense 1.64m / Debt 40.9m)
Taxrate = 28.05% (18.0m / 64.2m)
NOPAT = 114.0m (EBIT 158.4m * (1 - 28.05%))
Current Ratio = 1.83 (Total Current Assets 461.8m / Total Current Liabilities 252.6m)
Debt / Equity = 0.04 (Debt 40.9m / totalStockholderEquity, last quarter 911.0m)
Debt / EBITDA = -0.84 (Net Debt -209.6m / EBITDA 249.2m)
Debt / FCF = -0.99 (Net Debt -209.6m / FCF TTM 211.9m)
Total Stockholder Equity = 909.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.40% (Net Income 92.2m / Total Assets 1.25b)
RoE = 10.15% (Net Income TTM 92.2m / Total Stockholder Equity 909.1m)
RoCE = 17.41% (EBIT 158.4m / Capital Employed (Equity 909.1m + L.T.Debt 936.0k))
RoIC = 12.54% (NOPAT 114.0m / Invested Capital 909.1m)
WACC = 7.45% (E(2.13b)/V(2.17b) * Re(7.54%) + D(40.9m)/V(2.17b) * Rd(4.02%) * (1-Tc(0.28)))
Discount Rate = 7.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -5.65%
[DCF Debug] Terminal Value 80.93% ; FCFE base≈195.8m ; Y1≈232.9m ; Y5≈365.2m
Fair Price DCF = 727.5 (DCF Value 6.25b / Shares Outstanding 8.59m; 5y FCF grow 20.19% → 3.0% )
EPS Correlation: 41.59 | EPS CAGR: 146.9% | SUE: 0.91 | # QB: 3
Revenue Correlation: 22.06 | Revenue CAGR: 12.28% | SUE: -0.39 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.04 | Chg30d=-0.186 | Revisions Net=-5 | Analysts=7
EPS next Year (2026-12-31): EPS=10.90 | Chg30d=+0.189 | Revisions Net=+6 | Growth EPS=+17.3% | Growth Revenue=+1.3%
P/E Trailing = 22.7251
P/E Forward = 21.0084
P/S = 1.0764
P/B = 2.2919
P/EG = 0.7053
Beta = 1.059
Revenue TTM = 1.98b USD
EBIT TTM = 158.4m USD
EBITDA TTM = 249.2m USD
Long Term Debt = 936.0k USD (from longTermDebtTotal, last fiscal year)
Short Term Debt = 12.6m USD (from shortTermDebt, last quarter)
Debt = 40.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -209.6m USD (from netDebt column, last quarter)
Enterprise Value = 1.92b USD (2.13b + Debt 40.9m - CCE 250.5m)
Interest Coverage Ratio = 5.66 (Ebit TTM 158.4m / Interest Expense TTM 28.0m)
FCF Yield = 11.02% (FCF TTM 211.9m / Enterprise Value 1.92b)
FCF Margin = 10.69% (FCF TTM 211.9m / Revenue TTM 1.98b)
Net Margin = 4.66% (Net Income TTM 92.2m / Revenue TTM 1.98b)
Gross Margin = 47.72% ((Revenue TTM 1.98b - Cost of Revenue TTM 1.04b) / Revenue TTM)
Gross Margin QoQ = 50.81% (prev 49.75%)
Tobins Q-Ratio = 1.54 (Enterprise Value 1.92b / Total Assets 1.25b)
Interest Expense / Debt = 4.02% (Interest Expense 1.64m / Debt 40.9m)
Taxrate = 28.05% (18.0m / 64.2m)
NOPAT = 114.0m (EBIT 158.4m * (1 - 28.05%))
Current Ratio = 1.83 (Total Current Assets 461.8m / Total Current Liabilities 252.6m)
Debt / Equity = 0.04 (Debt 40.9m / totalStockholderEquity, last quarter 911.0m)
Debt / EBITDA = -0.84 (Net Debt -209.6m / EBITDA 249.2m)
Debt / FCF = -0.99 (Net Debt -209.6m / FCF TTM 211.9m)
Total Stockholder Equity = 909.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.40% (Net Income 92.2m / Total Assets 1.25b)
RoE = 10.15% (Net Income TTM 92.2m / Total Stockholder Equity 909.1m)
RoCE = 17.41% (EBIT 158.4m / Capital Employed (Equity 909.1m + L.T.Debt 936.0k))
RoIC = 12.54% (NOPAT 114.0m / Invested Capital 909.1m)
WACC = 7.45% (E(2.13b)/V(2.17b) * Re(7.54%) + D(40.9m)/V(2.17b) * Rd(4.02%) * (1-Tc(0.28)))
Discount Rate = 7.54% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -5.65%
[DCF Debug] Terminal Value 80.93% ; FCFE base≈195.8m ; Y1≈232.9m ; Y5≈365.2m
Fair Price DCF = 727.5 (DCF Value 6.25b / Shares Outstanding 8.59m; 5y FCF grow 20.19% → 3.0% )
EPS Correlation: 41.59 | EPS CAGR: 146.9% | SUE: 0.91 | # QB: 3
Revenue Correlation: 22.06 | Revenue CAGR: 12.28% | SUE: -0.39 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.04 | Chg30d=-0.186 | Revisions Net=-5 | Analysts=7
EPS next Year (2026-12-31): EPS=10.90 | Chg30d=+0.189 | Revisions Net=+6 | Growth EPS=+17.3% | Growth Revenue=+1.3%
Additional Sources for SAM Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle